Pfizer standalone net profit declines 2.39% in the March 2021 quarter

Sales rise 6.52% to Rs 534.76 crore

Net profit of Pfizer declined 2.39% to Rs 100.55 crore in the quarter ended March 2021 as against Rs 103.01 crore during the previous quarter ended March 2020. Sales rose 6.52% to Rs 534.76 crore in the quarter ended March 2021 as against Rs 502.01 crore during the previous quarter ended March 2020.

For the full year,net profit declined 2.26% to Rs 497.61 crore in the year ended March 2021 as against Rs 509.13 crore during the previous year ended March 2020. Sales rose 4.04% to Rs 2238.55 crore in the year ended March 2021 as against Rs 2151.65 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales534.76502.01 7 2238.552151.65 4 OPM %23.5121.65 -31.8126.61 - PBDT159.40150.31 6 778.13745.73 4 PBT132.09121.90 8 668.72642.49 4 NP100.55103.01 -2 497.61509.13 -2

Powered by Capital Market - Live News